查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490104

全球过敏治疗市场：按类型、治疗、分销管道、地区

Allergy Treatment Market, By Type, By Treatment, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球过敏治疗市场规模预计将从2024年的211.9亿美元增加到2031年的344.2亿美元，2024-2031年复合年增长率为7.2%。

报告范围 报告详情
基准年 2023年 2024年市场规模 211.9亿美元
实际资料 2019-2023 预测期 2024-2031
预测期 2024-2031 年复合年增长率 7.20% 2031年价值预测 344.2亿美元
图：2024 年按地区分類的过敏治疗市场占有率(%)
过敏治疗市场-IMG1

由于全球过敏性疾病盛行率不断上升，全球过敏治疗市场在过去几年中出现了显着增长。当免疫系统对灰尘、花粉和霉菌等环境过敏原反应过度时，就会引起过敏性疾病。据最近估计，全球有超过10亿人患有过敏性鼻炎。此外，污染水平的上升和生活方式的改变进一步增加了过敏的风险。因此，对有效治疗方案的需求不断增长，以控制各种过敏性疾病的症状，包括抗组织胺、减充血剂、皮质类固醇和过敏原免疫疗法。

市场动态：

全球过敏治疗市场受到污染水平上升、气候条件变化以及新兴国家医疗保健支出增加等因素的推动。然而，农村地区过敏治疗意识淡薄以及免疫治疗成本高昂限制了市场成长。开发具有改善功效的新型治疗剂为市场提供了利润丰厚的机会。各大公司都专注于研发先进的治疗方法来解决抗药性问题。然而，有关新过敏药物核准的严格规定是一个问题。

本研究的主要特点

  • 本报告对全球过敏治疗药物市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
  • 它还强调了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 基于公司亮点、产品系列、主要亮点、绩效和策略等参数的全球过敏治疗市场主要企业的概况。
  • 主要企业包括赛诺菲、诺华、葛兰素史克、强生服务公司、罗氏公司、Stallergenes Greer、Dermapharm Holding SE、Nicox、Allergy Therapeutics、艾伯维公司、梯瓦製药工业有限公司，其中包括Alembic Pharmaceuticals Limited 、ALK-Abello A/S、Bausch Health Companies Inc.、GLENMARK PHARMACEUTICALS LTD.、Perrigo Company plc、Dr Reddy's Laboratories Ltd.
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
  • 全球过敏治疗市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 透过用于分析全球过敏治疗市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 流行病学
  • 监管场景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球过敏治疗市场：COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球过敏治疗市场：依类型（2019-2031）

  • 眼睛过敏
  • 气喘
  • 鼻炎
  • 皮肤过敏
  • 食物过敏
  • 其他的

第六章全球过敏治疗市场：依治疗分类（2019-2031）

  • 抗过敏药
  • 免疫疗法

第七章全球过敏治疗市场：依通路划分（2019-2031）

  • 医院药房
  • 零售药房
  • 网路药房

第八章全球过敏治疗市场：按地区（2019-2031）

第9章 竞争格局

  • 公司简介
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson &Johnson Services, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

第10章分析师的观点

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map（COM）

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI5143

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 21.19 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.20% 2031 Value Projection: US$ 34.42 Bn
Figure. Allergy Treatment Market Share (%), By Region, 2024
Allergy Treatment Market - IMG1

The global allergy treatment market has been witnessing significant growth over the past few years owing to the rising prevalence of allergic disorders worldwide. Allergic disorders are caused when the immune system overreacts to environmental allergens such as dust, pollen, mold, etc. According to recent estimates, over 1 billion people globally suffer from allergic rhinitis. Additionally, the rising levels of pollution and changed lifestyle habits have further increased the risk of developing allergies. As a result, there has been a growing demand for effective treatment options such as antihistamines, decongestants, corticosteroids, and allergen immunotherapy for managing the symptoms of various allergic conditions.

Market Dynamics:

The global allergy treatment market is driven by factors such as increasing pollution levels, changing climate conditions, and rising healthcare expenditure in developing nations. However, the lack of awareness about allergy treatment in rural areas and high costs associated with immunotherapy restrain the market growth. The development of novel therapeutic drugs with improved efficacy offers lucrative opportunities in the market. Key players are focusing on R&D to develop advanced treatment regimens for tackling drug resistance issues. However, stringent regulations for approval of new allergy drugs pose a challenge

Key Features of the Study:

  • This report provides an in-depth analysis of the global allergy treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global allergy treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global allergy treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation-

  • By Type:
    • Eye Allergy
    • Asthma
    • Rhinitis
    • Skin Allergy
    • Food Allergies
    • Others
  • By Treatment:
    • Anti-allergy Drugs
    • Immunotherapy
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Allergy Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Allergy Treatment Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Eye Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Asthma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Rhinitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Skin Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Food Allergies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Allergy Treatment Market, By Treatment, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Anti-allergy Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Allergy Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Allergy Treatment Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stallergenes Greer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact